Log in here
Top Journalists
>
Erik Swain

Erik Swain

Author at healio.com at Healio

Contact this person
Email address
e*****@*******.comGet email address
Influence score
32
Location
United States
Languages
  • English
Covering topics

    View more media outlets and journalists by signing up to AI PR

    View latest data and reach out all from one place
    Sign up to AI PR Toolkit

    Recent Articles

    healio.com

    Inflammation, autoimmune diseases common threads in cardiology, dermatology, rheumatology

    BOSTON — Inflammation and autoimmune disease are common threads in cardiology, dermatology and rheumatology, and there is a need for collaboration across the disciplines, according to a speaker.“Cardio-rheumatology and -dermatology is an emerging subspeciality with a focus on better recognition of cardiovascular disease in this inherently higher-risk population,” Brittany Weber,
    10 days ago
    healio.com

    Cardiometabolic risk factors in midlife impact risk for dementia in...

    BOSTON — Vascular pathology and changes in midlife play a major role in brain health later in life, suggesting that reducing cardiometabolic risk factors may lower risk for dementia and Alzheimer’s disease, according to a speaker. “We now know with advances in neuroimaging that most people diagnosed with Alzheimer’s disease also have vascular injury and vice versa,”
    17 days ago
    healio.com

    CV benefits of semaglutide appear to be related to more than weight...

    Weight loss alone does not explain all of the cardiovascular benefits observed with semaglutide 2.4 mg in the SELECT trial, according to an analysis published in the European Heart Journal. “Several major trials have established that GLP-1 receptor agonists reduce serious cardiovascular disease, primarily in people with type 2 diabetes. SELECT was the first trial to show that these drugs
    22 days ago
    healio.com

    Catheter-directed thrombolysis succeeds in intermediate-high-risk a...

    MUNICH — Compared with anticoagulation alone, catheter-directed thrombolysis plus anticoagulation greatly reduced grave outcomes in patients with intermediate-high-risk acute pulmonary embolism, researchers reported. For the PRAGUE-26 trial, presented at the European Society of Cardiology Congress and simultaneously published in The New England Journal of Medicine, researchers randomly
    about 2 months ago
    healio.com

    Remote option does not increase participation in cardiac rehabilita...

    MUNICH — Remote exercise-based cardiac rehabilitation did not increase participation compared with center-based cardiac rehab in patients with heart attack, according to findings presented at the European Society of Cardiology Congress.However, patients with the option to use a remote exercise-based program had just as much improvement in physical capacity as those who had to use a
    2 months ago
    healio.com

    Digital strategy boosts prescriptions of SGLT2 inhibitors in patien...

    MUNICH — A digital strategy involving an emailed letter inviting patients with heart failure to be evaluated by a specialist for SGLT2 inhibitor therapy dramatically increased SGLT2 inhibitor prescriptions, researchers reported. For the EMAIL-HF registry-based randomized trial, presented at the European Society of Cardiology Congress, researchers identified all patients with HF in the
    2 months ago
    healio.com

    Personalized antibiotic strategy may be preferred for left-sided in...

    MUNICH — In patients with left-sided infective endocarditis, a response-tailored antibiotic strategy conferred more time alive without antibiotic therapy compared with standard duration therapy, new data show. For the POET II trial, presented at the European Society of Cardiology Congress and simultaneously published in The New England Journal of Medicine, the researchers randomly assigned
    2 months ago
    healio.com

    SGLT2 inhibitors linked to greater risk for major diabetic foot com...

    CHICAGO — Major diabetic foot complications were more common in patients with type 2 diabetes treated with SGLT2 inhibitors than those treated with GLP-1 receptor agonists, researchers reported at ENDO 2026.However, new-onset diabetic peripheral neuropathy was lower in patients taking SGLT2 inhibitors compared with those taking GLP-1s, according to the researchers.
    5 months ago
    healio.com

    NLRP3 inhibitor reduces inflammatory biomarkers in high-risk patients

    A novel NLRP3 inhibitor reduced high-sensitivity C-reactive protein and other inflammatory biomarkers in patients at high inflammatory risk, according to the results of a trial presented at the European Atherosclerosis Society Congress. The NLRP3 inhibitor, ruvonoflast (NodThera), “is designed to directly inhibit activation of the NLRP3 inflammasome in multiple clinically relevant cell
    5 months ago
    healio.com

    Automated insulin delivery system lowers HbA1c in patients with typ...

    NEW ORLEANS — In adults with insulin-treated type 2 diabetes, an automated insulin delivery system conferred lower HbA1c and improved time in range at 13 weeks, researchers reported at the American Diabetes Association Scientific Sessions. As Healio previously reported, the system (twiist, Sequel) received FDA clearance in 2024 for treatment of patients with type 1 diabetes aged 6
    5 months ago
    healio.com

    Novel pulsed field ablation technology successful in first-in-human...

    A novel pulsed field ablation technology was safe and prevented atrial arrhythmia recurrence in most patients with paroxysmal atrial fibrillation at 1 year, according to a first-in-human study presented at Heart Rhythm 2026. The circular nanosecond pulsed field ablation catheter (CellFX nsPFA 360, Pulse Biosciences) delivers nanosecond pulses as opposed to the microsecond pulses delivered by
    6 months ago